期刊文献+

特发性膜性肾病29例临床特点和治疗分析 被引量:1

下载PDF
导出
摘要 目的回顾性分析特发性膜性肾病(IMN)的临床表现、病理特点及治疗效果。方法选取2009年1月至2011年12月经过肾穿刺活检确诊的IMN患者29例,记录并分析各项临床资料。结果29例患者中年龄〉40岁22例,占75.9%。男女之比是1.64:1。19例(65.5%)患者临床表现为肾病综合征(NS)。主诉为水肿23例(79.3%)。泡沫尿14例(48.3%),伴血压升高7例(24.1%),伴镜下血尿21例(72.4%),伴。肾功能不全1例(3.4%)。IMN患者24h尿蛋白定量明显增加,血清白蛋白明显降低,血脂明显升高,总钙明显降低,纤维蛋白原(FIB)明显升高,免疫球(FIB)蛋白G明显降低(P〈0.01),高密度脂蛋白和补体C3与正常参考值比较差异无统计学意义(P〉0.05)。IMN肾脏病理改变以Ⅰ期、Ⅰ~Ⅱ期和Ⅱ期为主,共占96.6%。其中10例(34.5%)具有小管间质损伤。13例随诊患者中治疗12个月时8例(61.5%)完全缓解,4例(30.8%)部分缓解。结论IMN多见于中老年,男多于女,其临床表现、实验室检查、病理学表现存在一定的特点和规律,激素联合环磷酰胺冲击治疗的方案有效。 Objective To retrospectively analyze clinical manifestations, pathological changes and therapeutic effects of idiopathic membranous nephropathy ( IMN ) . Methods 29 patients with IMN were recruited according to the results of kidney biopsy. All of the clinical data was recorded and analyzed. Results The patients aged over 40 years old accounted for 75.9%. The ratio of men to women was 1.64: 1. The patients with nephrotic syndrome ( NS ) accounted for 65.5%. 23 cases (79.3%) had a chief complaint of edema. 14 cases (48.3%) had bubble urine. 7 cases (24.1%) had elevated blood pressure. 21 cases ( 72.4% ) had microscopic hematuria. One case ( 3.4% ) had renal insufficiency. 24h urine protein, blood lipids ( TC, TG, LDL, Lpa ) and FIB increased significantly ( P〈0.01 ) . Serum albumin, total calcium and IgG reduced significantly ( P〈0.01 ) . There were not significant differences in the levels of HDL and C3 compared with the normal reference values (P〉0.05) . The cases of MN stage I , stage I - lI and stage ]] accounted for 96.6%. 10 cases ( 34.5% ) had renal tubulointerstitial injury. 8 cases ( 61.5% ) experienced complete remission, 4 cases ( 30.8% ) experienced partial remission in 13 follow-up patients. Conclusion IMN is more commonly found in middle and old people and males patients are more than females. There are certain features and regularities upon its clinical manifestations, laboratory tests and pathological changes. The therapeutic regimen of corticosteroids combined with pulse cyclophosphamide is effective.
出处 《浙江临床医学》 2013年第9期1289-1291,共3页 Zhejiang Clinical Medical Journal
关键词 膜性肾病 肾病综合征 病理 药物治疗 Membranous nephropathy Nephrotic syndrome Pathology Drug therapy
  • 相关文献

参考文献13

  • 1Ponticelli C. Membranous nephropathy. J Nephrol, 2007, 20 (3): 268-287.
  • 2Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13, 519 renal biopsies. Kidney Int, 2004, 66 (3): 920-923.
  • 3梁世凯,许菲菲,舒桂琴,吕吟秋,邵蓉蓉,刘毅.70例特发性膜性肾病的临床特点和治疗探讨[J].中国中西医结合肾病杂志,2006,7(10):595-597. 被引量:9
  • 4林钐,邓跃毅,陈以平,蔡如慧.特发性膜性肾病患者脂蛋白(a)水平的临床观察[J].中国中西医结合肾病杂志,2009,10(8):712-713. 被引量:2
  • 5Keane WF, Kasiske BL, O'Donnell MP. Lipids and progressive glomemlosclerosis. A model analogous to atherosclerosis. AmJ Nephrol, 1988, 8: 261-271.
  • 6Mittal SK, Dash SC, Tiwari SC, et al. Bone histology in patients with nephrotic syndrome and normal renal function. Kidney lnt, 1999, 55 (5):1912-1919.
  • 7王海燕.肾脏病学锑三版.北京:人民卫生出版社,2008.942-944.
  • 8Shiiki H, saito T, Nishitani Y, et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int, 2004, 65(4):1400-1407.
  • 9Wehrmann M, Bohle A, Bogenschiitz O, et al. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes. Clin Nephrol, 1989, 31(2): 67-76.
  • 10Ponticelli C, Altieri P, Scolari F, et al. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol, 1998, 9 (3): 444-450.

二级参考文献12

  • 1林小军,蔡小燕.系统性红斑狼疮患者肾损害与血清脂蛋白(a)水平相关性分析[J].实用医学杂志,2006,22(7):773-774. 被引量:10
  • 2Nakamura S, Sasaki O, Nakahama H, et al. Clinical characteristics and survival in end - stage renal disease patients with arteriosclerosis obliterans. Am J Nephrol, 2002,22 (5) : 422 - 428.
  • 3Kronenberg F, Lingenhel A, Lhotta K, et al, Lipoprotein(a) and low-density lipoprotein- derived cholesterol in nephrotic syndrome: impact on lipid - lowering therapy. Kidney Int, 2004,66 (1):348.
  • 4Uhlig K, Wang SR, Beck GJ, et al. Factors associated with lipoprotein(a) in chronic kidney diease. Am J Kidney Dis, 2005,45 ( 1) : 28 - 38.
  • 5Scheidat S,Stahl RA.Membranous glomerulonephritis.Internist (Berl),2003,44(9):1120-1130.
  • 6Shiiki H,Saito T,Nishitani Y,et al.Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan.Kidney Int,2004,65(4):1400-1407.
  • 7Ponticelli C,Altieri P,Scolari F,et al.A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.J Am Soc Nephrol,1998,9(3):444-450.
  • 8周兴辉.肾病综合征患者血浆脂蛋白(a)水平与纤溶活性变化的研究[J].全科医学临床与教育,2008,6(3):201-203. 被引量:4
  • 9赵明辉,陈香美,谌贻璞,刘章锁,刘玉春,卢方平,张燕萍,王海燕.霉酚酸酯治疗原发性肾病综合征的临床观察[J].中华医学杂志,2001,81(9):528-531. 被引量:105
  • 10朱红枫,朱正芳,周正秀,何利璋.儿童肾脏病血清脂蛋白(a)水平及临床意义[J].中国优生与遗传杂志,2002,10(1):37-37. 被引量:3

共引文献9

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部